Health Care: Drugs

Tekmira Pharmaceuticals Corp (TKMR: NASDAQ)

$18.17 -0.22 | -1.2%
02/27/15 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 18.39
52 Week High 31.48
52 Week Low 8.86
Avg. Daily Vol. (Mil) 0.98
Beta (3 year) -0.09
Share Related Items
Mkt Cap (Mil) 412.96
Shares Out (Mil) 22.31
Float (Mil) 21.83
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 5.70
Current Ratio 5.70
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 22.62
Price/Book 4.30
Price/Cash Flow -11.80
Per Share Data
Earnings -1.70
Sales 0.81
Book Value 4.28
Cash Flow -1.56
Business Summary
Tekmira Pharmaceuticals Corp develops ribonucleic acid interference therapeutic product candidates as well as provides its lipid nanoparticle delivery technology to pharmaceutical partners in the Canada.
General Information
100 - 8900 Glenlyon Parkway
Burnaby, BC V5J 5J8
www.tekmirapharm.com
Industry : Drugs
Sector: Health Care
Employees: 92
CEO: Dr. Mark J. Murray,PhD
Short Interest
Current Month (Mil) 3.56
Previous Month (Mil) 3.48
Short Interest Ratio (Days) 3.70
Management Effectiveness
Return on Equity n.a.
Return on Assets -28.20
Return on Investments -36.90
Profitability
Gross Margin -86.30
EBIT Margin n.a.
Profit Margin 0.00

Partner Headlines for TKMR

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter